Home/Traverse Biotech/Jean-Loup Romet-Lemonne, MD
JR

Jean-Loup Romet-Lemonne, MD

Co-Founder & President

Traverse Biotech

Therapeutic Areas

Traverse Biotech Pipeline

DrugIndicationPhase
CD3 X ROR2 DuoBodyMultiple Oncology IndicationsPreclinical
Targeting Innate ImmunityOncology and AgingResearch